PCVX insider trading — Vaxcyte, Inc.
Over the last 90 days, insiders at Vaxcyte, Inc. (PCVX) made 0 open-market purchases worth $0 and 3 open-market sales worth $376K, making them net sellers by $376K. The largest sale was by Wassil Jim (CHIEF OPERATING OFFICER), who sold 3,477 shares for $212K on Sep 1, 2026.
Updated Oct 16, 2026.
Recent PCVX insider transactions
Every Form 4 filed by Vaxcyte, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | M · Option exercise · 10b5-1 | Direct | 18,000 | $5.35 | $96K | Form 4 |
| Oct 5, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | S · Sale · 10b5-1 | Direct | 18,000 | $86.74 | $1.56M | Form 4 |
| Oct 5, 2026 | Cowan Elvia | SVP, Finance & CAO | M · Option exercise · 10b5-1 | Direct | 19,000 | $25.92 | $492K | Form 4 |
| Oct 5, 2026 | Cowan Elvia | SVP, Finance & CAO | S · Sale · 10b5-1 | Direct | 19,000 | $86.74 | $1.65M | Form 4 |
| Oct 1, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | M · Option exercise · 10b5-1 | Direct | 2,250 | $5.35 | $12K | Form 4 |
| Oct 1, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | S · Sale · 10b5-1 | Direct | 2,250 | $56.67 | $128K | Form 4 |
| Sep 8, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | F · Tax withholding | Direct | 17,056 | $60.36 | $1.03M | Form 4 |
| Sep 8, 2026 | Guggenhime Andrew | PRESIDENT AND CFO | F · Tax withholding | Direct | 7,155 | $60.36 | $432K | Form 4 |
| Sep 8, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | F · Tax withholding | Direct | 7,651 | $60.36 | $462K | Form 4 |
| Sep 8, 2026 | Cowan Elvia | SVP, Finance & CAO | F · Tax withholding | Direct | 1,327 | $60.36 | $80K | Form 4 |
| Sep 9, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | S · Sale | Direct | 1,334 | $59.52 | $79K | Form 4 |
| Sep 8, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | F · Tax withholding | Direct | 5,459 | $60.36 | $330K | Form 4 |
| Sep 4, 2026 | Wassil Jim | EVP, Chief Scientific Ofc, COO | S · Sale | Direct | 1,381 | $61.16 | $84K | Form 4 |
| Sep 4, 2026 | Jodar Luis | Chief Medical Officer | A · Grant/award | Direct | 52,632 | — | — | Form 4 |
| Sep 2, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | F · Tax withholding | Direct | 1,432 | $61.58 | $88K | Form 4 |
| Sep 1, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | M · Option exercise | Direct | 2,250 | $5.35 | $12K | Form 4 |
| Sep 1, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | S · Sale | Direct | 3,477 | $61.07 | $212K | Form 4 |
| Aug 31, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | F · Tax withholding | Direct | 1,273 | $60.74 | $77K | Form 4 |
| Sep 2, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | F · Tax withholding | Direct | 3,427 | $61.58 | $211K | Form 4 |
| Aug 31, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | F · Tax withholding | Direct | 2,862 | $60.74 | $174K | Form 4 |
| Sep 2, 2026 | Guggenhime Andrew | PRESIDENT AND CFO | F · Tax withholding | Direct | 1,432 | $61.58 | $88K | Form 4 |
| Sep 2, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | F · Tax withholding | Direct | 659 | $61.58 | $41K | Form 4 |
| Aug 31, 2026 | Guggenhime Andrew | PRESIDENT AND CFO | F · Tax withholding | Direct | 1,273 | $60.74 | $77K | Form 4 |
| Aug 31, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | F · Tax withholding | Direct | 361 | $60.74 | $22K | Form 4 |
| Sep 2, 2026 | Cowan Elvia | SVP, Finance & CAO | F · Tax withholding | Direct | 326 | $61.58 | $20K | Form 4 |
| Aug 31, 2026 | Cowan Elvia | SVP, Finance & CAO | F · Tax withholding | Direct | 243 | $60.74 | $15K | Form 4 |
| Aug 5, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | M · Option exercise · 10b5-1 | Direct | 17,000 | $24.79 | $421K | Form 4 |
| Aug 5, 2026 | Dhaliwal Harpreet S. | Chief Technical Ops Officer | S · Sale · 10b5-1 | Direct | 17,000 | $55.00 | $935K | Form 4 |
| Aug 3, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | M · Option exercise · 10b5-1 | Direct | 2,250 | $5.35 | $12K | Form 4 |
| Aug 3, 2026 | Wassil Jim | CHIEF OPERATING OFFICER | S · Sale · 10b5-1 | Direct | 2,250 | $53.86 | $121K | Form 4 |
| Aug 3, 2026 | Guggenhime Andrew | PRESIDENT AND CFO | M · Option exercise · 10b5-1 | Direct | 10,000 | $5.35 | $54K | Form 4 |
| Aug 3, 2026 | Guggenhime Andrew | PRESIDENT AND CFO | S · Sale · 10b5-1 | Direct | 10,000 | $53.89 | $539K | Form 4 |
| Jul 27, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | M · Option exercise · 10b5-1 | Direct | 16,198 | $2.03 | $33K | Form 4 |
| Jul 27, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | S · Sale · 10b5-1 | Direct | 16,198 | $55.63 | $901K | Form 4 |
| Jul 27, 2026 | Pickering Grant | CHIEF EXECUTIVE OFFICER | S · Sale · 10b5-1 | Indirect | 2,000 | $55.65 | $111K | Form 4 |
PCVX insider trading FAQ
Are insiders buying PCVX stock?
Not on the open market. In the last 90 days, Vaxcyte, Inc. insiders made no open-market purchases, and 3 open-market sales totaling $376K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading PCVX?
Recent sellers: Wassil Jim.
Where does PCVX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.